Dr. Reddy’s Laboratories advances on receiving EIR from USFDA

23 Aug 2018 Evaluate

Dr. Reddys Laboratories is currently trading at Rs. 2470.00, up by 57.55 points or 2.39% from its previous closing of Rs. 2412.45 on the BSE.

The scrip opened at Rs. 2421.05 and has touched a high and low of Rs. 2518.50 and Rs. 2421.05 respectively. So far 112427 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 2611.80 on 24-Jan-2018 and a 52 week low of Rs. 1888.00 on 21-May-2018.

Last one week high and low of the scrip stood at Rs. 2,518.50 and Rs. 2,269.55 respectively. The current market cap of the company is Rs. 40918.71 crore.

The promoters holding in the company stood at 26.79%, while Institutions and Non-Institutions held 44.27% and 14.60% respectively.

Dr. Reddy’s Laboratories has received an Establishment Inspection Report (EIR) from the United States Food & Drug Administration (USFDA), for API Srikakulam Plant (SEZ) Andhra Pradesh.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

5888.65 -29.90 (-0.51%)
14-May-2024 11:22 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1539.00
Dr. Reddys Lab 5888.65
Cipla 1371.95
Zydus Lifesciences 988.30
Lupin 1636.60
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.